Hinge Health, "the San Francisco-based company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions, like back and joint pain," recently secured $400 million in Series E funding. The new funding was co-lead by Tiger Global and Coatue Management, alongside Alkeon Capital and Whale Rock.
The new investment brings Hinge Health's total funds raised to over $1 billion and is “now one of the most valuable companies in digital health.” To help lead the company, Hinge Health recently welcomed Lalith Vadlamannati as its new chief technology officer.
Hinge Health offers revolutionary technology that reduces MSK pain, surgeries, and opioid use. The brand features advanced wearable sensors and computer technology that is overseen by physical therapists, physicians, and board-certified health coaches.
Image Credit: Hinge Health
Why This Trend Is Growing
- Digital Health Solutions
- Investments in companies that offer digital health solutions, like Hinge Health, that can reduce pain, surgeries, and opioid use are expected to grow.
- Chronic Pain Treatment
- Investments in companies that offer digital solutions to treat chronic musculoskeletal conditions like back and joint pain are predicted to become more common.
- Remote Health Monitoring
- Investments in digital health platforms that enable remote health monitoring for chronic conditions are expected to rise, allowing patients to receive care from the comfort of their own homes.
Industries Being Reshaped
- Digital Health
- Digital health companies that offer solutions for chronic pain conditions, like Hinge Health, are poised for growth and investment opportunities.
- Wearable Technology
- Investments in wearable technology that can monitor and track chronic conditions, like those offered by Hinge Health, could disrupt the healthcare industry and create new opportunities for innovation.
- Healthcare Technology
- Innovative healthcare technology companies, like Hinge Health, that use advanced sensors and computer analytics to improve patient outcomes are attracting interest from investors and could potentially change the way healthcare is delivered.
